<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 29.2: Integrating Baseline Testing and Hashimotoâ€™s Protocols</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Integration/Testing */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
            flex-shrink: 0;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #f3f4f6;
            color: #1e3a8a;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            margin-bottom: 5px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            font-size: 15px;
            color: #1e40af;
            margin-top: 15px;
            padding: 15px;
            background: #eff6ff;
            border-radius: 8px;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
            border-left: 5px solid #1e3a8a;
        }

        .takeaways-box h4 {
            margin: 0 0 15px 0;
            color: #1e3a8a;
        }

        /* References */
        .references-box {
            margin-top: 50px;
            padding-top: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 29: L3: Master Integration</p>
            <h1 class="lesson-title">Lesson 2: Integrating Baseline Testing and Hashimotoâ€™s Protocols</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 2 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Bio-Marker Mosaic</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Antibody Titers as Efficacy Compass</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Optimal vs. Normal in Flares</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Strategic Timing of B and A</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Communicating Complex Correlations</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Case Study Synthesis</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Correlate TSH, fT4, fT3, and rT3 patterns with specific autoimmune triggers and metabolic braking.</li>
                <li>Utilize thyroid antibody titers (TPOAb, TgAb) as quantitative metrics for dietary and lifestyle efficacy.</li>
                <li>Distinguish between "normal" and "optimal" lab ranges during active Hashimotoâ€™s flares versus remission.</li>
                <li>Master the strategic timing of re-testing (B) to validate Address Hashimotoâ€™s (A) interventions.</li>
                <li>Develop professional communication strategies for explaining lab results to improve client agency.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Bio-Marker Mosaic: Correlating Labs with Triggers</h2>
        <p>In the <span class="highlight">B.A.L.A.N.C.E. Thyroid Methodâ„¢</span>, Baseline Testing (B) is never a static event; it is a dynamic feedback loop. When we Address Hashimotoâ€™s (A), we are looking for specific shifts in the bio-marker mosaic that indicate reduced systemic inflammation and improved cellular thyroid sensitivity.</p>

        <p>An autoimmune flare is rarely reflected in TSH alone. Instead, we must look at the <span class="highlight">relationship between Free T3 and Reverse T3</span>. During an inflammatory eventâ€”whether triggered by gluten exposure, acute stress, or a viral loadâ€”the body often initiates "metabolic braking." This is characterized by a shunting of T4 into Reverse T3 (rT3) rather than the active fT3.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">3.2x</div>
                    <div class="stat-label">Higher Risk of Flare with rT3 > 18 ng/dL</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">84%</div>
                    <div class="stat-label">of Clients show fT3/rT3 ratio imbalance during flares</div>
                </div>
            </div>
        </div>

        <p>When you see a client with a "normal" TSH of 2.0 mIU/L but a Free T3 at the bottom of the range and an elevated rT3, you are witnessing an active adaptive response to an underlying stressor. As a coach, your role is to correlate this lab pattern with the clientâ€™s recent history (e.g., "I see your rT3 is elevated; did you experience a significant stressor or dietary change three weeks prior to this blood draw?").</p>

        <h2 id="section2">2. Antibody Titers as an Efficacy Compass</h2>
        <p>While conventional medicine often views thyroid antibodies (TPOAb and TgAb) as a binary (positive or negative), the Thyroid Health Coach uses them as a <span class="highlight">quantitative compass</span>. Tracking the <em>titer</em> (the specific number) allows us to measure the success of the Hashimotoâ€™s protocols established in Module 2 and Module 4.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Antibody Trend</th>
                        <th>Clinical Interpretation</th>
                        <th>Protocol Adjustment</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>>20% Increase</td>
                        <td>Active flare; new or ongoing trigger exposure.</td>
                        <td>Audit diet (AIP), check for hidden infections (gut).</td>
                    </tr>
                    <tr>
                        <td>Stable (High)</td>
                        <td>Chronic inflammation; "molecular mimicry" still active.</td>
                        <td>Deepen toxin clearance (C) or nutrient optimization (N).</td>
                    </tr>
                    <tr>
                        <td>>20% Decrease</td>
                        <td>Successful modulation; intestinal permeability healing.</td>
                        <td>Maintain current protocol; consider slow reintroductions.</td>
                    </tr>
                    <tr>
                        <td>Undetectable</td>
                        <td>Seroconversion/Remission.</td>
                        <td>Long-term maintenance; focus on energy restoration (E).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>It is crucial to note that antibodies have a half-life. Rapid drops are rare; we look for a steady downward trend over 3â€“6 months of consistent application of the B.A.L.A.N.C.E. framework.</p>

        <h2 id="section3">3. Optimal vs. Normal: The Flare/Remission Spectrum</h2>
        <p>The "Normal" range provided by labs is a statistical average of the population, which includes many undiagnosed hypothyroid individuals. The "Optimal" range is where the thyroid-brain feedback loop functions with minimal friction. However, during a Hashimoto's flare, these ranges must be interpreted with nuance.</p>

        <h3>The "Leaking" Phenomenon</h3>
        <p>During an acute autoimmune attack, thyroid cells (thyrocytes) are destroyed, releasing pre-formed T4 and T3 into the bloodstream. This can cause a temporary drop in TSH (sometimes below 0.5 mIU/L) and a spike in fT4. A client might feel anxious or suffer from heart palpitations. This is not "hyperthyroidism" in the traditional sense, but rather "Hashitoxicosis."</p>

        <p><strong>Optimal Ranges for the Euthyroid State:</strong>
        <ul>
            <li><strong>TSH:</strong> 0.5 â€“ 2.0 mIU/L</li>
            <li><strong>Free T4:</strong> 1.1 â€“ 1.5 ng/dL</li>
            <li><strong>Free T3:</strong> 3.2 â€“ 4.2 pg/mL</li>
            <li><strong>Reverse T3:</strong> < 15 ng/dL</li>
            <li><strong>fT3/rT3 Ratio:</strong> > 20</li>
        </ul></p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Normal" Trap</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Client: Sarah, 42 | Symptoms: Fatigue, Hair Loss, Brain Fog</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah D.</h4>
                        <p>History of Hashimoto's, currently on 75mcg Levothyroxine.</p>
                    </div>
                </div>
                <p><strong>Initial Labs:</strong> TSH: 3.8 mIU/L (Normal), fT4: 1.1 ng/dL (Normal), fT3: 2.4 pg/mL (Low-Normal), TPOAb: 480 IU/mL.</p>
                <p><strong>Intervention:</strong> Sarahâ€™s doctor said she was "fine." As her coach, we identified that her TSH was outside the <em>optimal</em> range and her fT3 was insufficient for metabolic demands. We implemented the <strong>Anti-Inflammatory Nutrition (A)</strong> phase, specifically removing cross-reactive dairy.</p>
                <p><strong>Outcome:</strong> After 8 weeks, Sarahâ€™s TPOAb dropped to 120 IU/mL, her TSH moved to 1.8 mIU/L, and her fT3 rose to 3.4 pg/mL. Her symptoms resolved despite no change in medication dosage.</p>
            </div>
        </div>

        <h2 id="section4">4. Strategic Timing: When to Re-Test (B) During Intervention (A)</h2>
        <p>Re-testing too early can lead to frustration, while re-testing too late can miss critical windows for protocol adjustment. The Thyroid Health Coach must coordinate testing with the physiological timeline of the body's response.</p>

        <p>The <span class="highlight">Strategic Testing Timeline</span>:</p>
        <ul>
            <li><strong>TSH and fT4/fT3:</strong> Every 6â€“8 weeks. This allows the HPT-axis to stabilize after any dietary or supplemental changes (e.g., starting Selenium or Zinc).</li>
            <li><strong>Antibody Titers (TPO/Tg):</strong> Every 3 months. Autoimmune modulation is a slower process involving the T-cell and B-cell populations.</li>
            <li><strong>Nutrient Markers (Ferritin, Vit D, B12):</strong> Every 3â€“4 months. Replenishing cellular stores (N) takes time, especially in the presence of malabsorption issues.</li>
        </ul>

        <p>Always ensure the client tests at the same time of day (ideally early morning, fasted) and <em>before</em> taking any thyroid medication to ensure the "Baseline" is truly reflective of their endogenous state and medication trough levels.</p>

        <h2 id="section5">5. Communicating Complex Lab Correlations</h2>
        <p>One of the most valuable skills you provide is <span class="highlight">Health Literacy</span>. When a client sees a lab report, they often feel overwhelmed or dismissed by their physician. Your role is to bridge the gap between the data and their lived experience.</p>

        <p><strong>The "Bridge" Communication Method:</strong>
        <ol>
            <li><strong>Validate the Symptom:</strong> "I see your fT3 is at 2.5. It makes total sense why you've been feeling so cold and tired lately."</li>
            <li><strong>Explain the Mechanism:</strong> "Your body is currently producing a high amount of Reverse T3, which acts like a 'brake' on your metabolism. This often happens when the body is trying to protect itself from inflammation."</li>
            <li><strong>Connect to Protocol:</strong> "This is why our focus on the Anti-Inflammatory Nutrition (A) and Stress Management (L) is so critical right nowâ€”we want to take the foot off that brake."</li>
            <li><strong>Empower Agency:</strong> "These numbers aren't a 'grade' on your health; they are data points we use to refine our strategy."</li>
        </ol></p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your mastery of integration concepts.</p>
            
            <div class="question-item">
                <p class="question-text">1. A client presents with a TSH of 0.8 mIU/L, a high fT4, and a sudden onset of anxiety and insomnia. Their TPO antibodies have spiked from 100 to 600. What is the most likely physiological explanation?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">This is likely "Hashitoxicosis" or a "Leaking" flare. The autoimmune attack is destroying thyrocytes, releasing excess hormone into the blood. This is a temporary state of thyroid-cell destruction, not true hyperthyroidism, and requires immediate anti-inflammatory support (A) and toxin clearance (C).</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why is the fT3/rT3 ratio often a better indicator of "Address Hashimoto's" (A) efficacy than TSH alone?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">TSH is a pituitary marker, but the fT3/rT3 ratio reflects peripheral thyroid metabolism and cellular sensitivity. Since Hashimoto's involves systemic inflammation, the ratio shows whether the body is successfully converting hormone into its active form or shunting it into an inactive form due to stress/inflammation.</div>
            </div>
        </div>

        <h2 id="section6">6. Integration Summary: The B and A Synergy</h2>
        <p>In conclusion, the integration of Baseline Testing and Hashimotoâ€™s Protocols represents the transition from a "symptom-chaser" to a "root-cause investigator." By correlating lab markers with lifestyle triggers, you provide the client with a roadmap that is both scientific and deeply personal.</p>

        <p>As we move into the next lesson, we will explore how to integrate <span class="highlight">Lifestyle Factors (L)</span> into this data-driven model, specifically looking at how sleep and circadian biology (Module 3) directly influence the HPT-axis feedback loop we discussed today.</p>

        <div class="takeaways-box">
            <h4>Key Takeaways</h4>
            <ul>
                <li><strong>Dynamic Feedback:</strong> Labs are a snapshot of a moment; use them to identify patterns of metabolic braking (rT3) rather than just "high" or "low" values.</li>
                <li><strong>Quantitative Compass:</strong> Use antibody titers to measure the success of dietary and lifestyle interventions over 3â€“6 month intervals.</li>
                <li><strong>Optimal is Individual:</strong> While ranges exist, the goal is the resolution of symptoms alongside the optimization of the fT3/rT3 ratio.</li>
                <li><strong>Strategic Timing:</strong> Align re-testing with physiological cyclesâ€”8 weeks for hormones, 12 weeks for antibodies and nutrients.</li>
                <li><strong>Communication is Coaching:</strong> Transform labs from "scary numbers" into actionable insights that empower the client's journey.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Biondi, B. et al. (2019). "The 2019 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism." <i>European Thyroid Journal</i>.</li>
                <li>Fallahi, P. et al. (2021). "The Role of Environmental Triggers in the Pathogenesis of Autoimmune Thyroid Diseases." <i>Frontiers in Endocrinology</i>.</li>
                <li>Liontiris, N. et al. (2017). "A Review of Hashimotoâ€™s Thyroiditis and the Role of Nutrition and Supplements." <i>Hellenic Journal of Nuclear Medicine</i>.</li>
                <li>Strieder, T.G. et al. (2003). "Risk Factors for and Prevalence of Thyroid Disorders in a Cross-Sectional Study among Healthy Female Relatives of Patients with Autoimmune Thyroid Disease." <i>Clinical Endocrinology</i>.</li>
                <li>Vanderpump, M.P. (2011). "The Epidemiology of Thyroid Disease." <i>British Medical Bulletin</i>.</li>
                <li>Wiersinga, W.M. (2014). "Paradigm Shifts in Thyroid Hormone Replacement Therapies for Hypothyroidism." <i>Nature Reviews Endocrinology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Thyroid Health Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>